Increasing prevalence of chronic diseases, technological advancements in surgical lasers, increasing incidence and prevalence of targeted diseases, and high prevalence of ophthalmic disorders are the major factors driving the growth of this market. In addition, growing preference for minimally invasive surgeries are further adding to the growth prospects of this market.
Major Market Restraints:
# High Procedural Costs Associated With Laser Surgeries
# Limited Medical Reimbursements
# Stringent Government Regulations
Major Market Opportunities:
# Emerging Markets
# Growing Trend of Medical Tourism
North America is expected to hold the largest share of the global surgical lasers market, followed by Europe in 2016. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. Factors driving market growth in the Asia-Pacific region include the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population), rising awareness among healthcare professionals related to the procedural benefits of surgical laser products, and increasing government initiatives to reduce the burden of ophthalmic disorders.
Download PDF Brochure@
As of 2015, global surgical lasers market was dominated by Lumenis (Israel), Cynosure, Inc. (U.S.), and Alma Lasers (Israel), among others.
Lumenis held the leading position in the global surgical lasers market, as of 2015. The company offers a wide range of surgical laser products (such as UltraPulse DUO CO2 Surgical Laser, UltraPulse SurgiTouch, AcuPulse 40 WG, and Lumenis Pulse 30H) worldwide. The company adopted product launches as its key strategy to maintain its leading position in the global surgical lasers market. For instance, during 2013-2016, the company launched several innovative products such as OtoLase (September 2016) and UltraPulse DUO CO2 advanced laser platform for ENT applications (June 2016). Such initiatives helped the company to expand its product portfolio and to address unmet needs of its customers across major markets worldwide.
Cynosure, Inc. held a noteworthy position in the global surgical lasers market, as of 2015. The company focused mainly on two major business strategies: technological development in aesthetic laser applications and capability expansion (through acquisitions and partnerships). In line with this strategy, in January 2016, Cynosure, Inc. launched SculpSure; a non-invasive body contouring product that uses patented light-based technology to eliminate fat cells without surgery. Similarly, in June 2013, Cynosure acquired Palomar Medical Technologies Inc. (U.S.) to strengthen its market presence in the U.S. medical lasers market.
Moreover, during 2013-2016, majority of the leading players are adopting strategies such as product launches, product enhancements, acquisitions, and agreements to maintain or to strengthen their market position in global surgical lasers market. The market players are also focusing on increasing their product portfolios by expanding their production capabilities and distribution networks to cater to the growing demand for surgical lasers. Other players operating in the surgical lasers market are Alma Lasers (Israel), Abbott Laboratories, Inc., (U.S.), Boston Scientific Corporation (U.S.), IPG Photonics Corporation (U.S.), Spectranetics Corporation (U.S.), Biolitec AG (Austria), Fotona d.o.o. (Slovenia), and BISON MEDICAL Co., Ltd. (South Korea), among others.
Read More@
Target Audience:
# Surgical laser product manufacturing companies
# Product suppliers and distributors
# Healthcare service providers [including hospitals, specialty clinics, and ambulatory surgery centers (ASCs)]
# Research laboratories and academic institutes
# Clinical research organizations (CROs)
# Government regulatory authorities
# Independent authorities and non-government organizations
# Market research and consulting firms
# Venture capitalists
No comments:
Post a Comment